Zymeworks (ZYME) Change in Accured Expenses (2021 - 2026)

Zymeworks' Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$7.8 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 63.48% year-over-year to -$7.8 million; the TTM figure through Mar 2026 stood at -$10.2 million (down 10.93% YoY), while the FY2025 annual figure was -$23.6 million, down 265.13% from the prior year.
• Change in Accured Expenses came in at -$7.8 million for Q1 2026 at Zymeworks, down from $1.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $37.6 million in Q4 2022 to a low of -$28.3 million in Q1 2023.
• A 5-year average of -$2.1 million and a median of $1.3 million in 2025 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 551.75% in 2022 and slumped 1031.47% in 2025, its largest moves.
• Zymeworks' Change in Accured Expenses stood at $37.6 million in 2022, then plunged by 159.42% to -$22.3 million in 2023, then surged by 132.87% to $7.3 million in 2024, then slumped by 81.8% to $1.3 million in 2025, then sank by 680.52% to -$7.8 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$7.8 million, $1.3 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison